Kok‐Yong Seng - Concepedia

Author

Kok‐Yong Seng

DSO National Laboratories

Also Known As

KOK-YONG SENG, Kok-Yong Seng, Kok-yong Seng, Kok‐Yong Seng

Publications

406

Citations

H-Index

Concepts

All Affiliations

DSO National Laboratories National University of Singapore National University Health System Defence Science and Technology Agency University of Washington

About

Kok‐Yong Seng is an author at DSO National Laboratories specializing in medicine, pharmacology, and pharmacokinetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	178
2	Engineering	2	2	23
3	Health Sciences	2	2	71
4	Applied Physiology	1	1	59
5	Emergency Medicine	1	1	12

Kok‐Yong Seng

Publications

338

Citations

H-Index

Page 1

	Year	Citations
Neck muscle strength across the sagittal and coronal planes: an isometric study Kok‐Yong Seng, V. Peter, Pin-Min Lam Clinical Biomechanics Neck Muscle StrengthKinesiologyNeuromuscular CoordinationExercise PhysiologyMusculoskeletal Function	2002	59
Postoperative Ketorolac Tromethamine Use in Infants Aged 6–18 Months: The Effect on Morphine Usage, Safety Assessment, and Stereo-Specific Pharmacokinetics Anne M Lynn, Heidi Bradford, Eric D. Kantor, Anesthesia & Analgesia	2007	51
Population Pharmacokinetic Analysis of Isoniazid, Acetylisoniazid, and Isonicotinic Acid in Healthy Volunteers Kok‐Yong Seng, Kim‐Hor Hee, Gaik‐Hong Soon, Antimicrobial Agents and Chemotherapy Inh PharmacokineticsPopulation Pharmacokinetic AnalysisPharmacotherapyPharmacokineticsIsonicotinic Acid	2015	50
Pharmacokinetic Modeling of Plasma and Intracellular Concentrations of Raltegravir in Healthy Volunteers Lingzhi Wang, Gaik Hong Soon, Kok‐Yong Seng, Antimicrobial Agents and Chemotherapy Hiv IntegraseImmunologyPharmacotherapyApparent PlasmaAntiviral Drug	2011	37
Population pharmacokinetics of rifampicin and 25-deacetyl-rifampicin in healthy Asian adults Kok‐Yong Seng, Kim‐Hor Hee, Gaik‐Hong Soon, Journal of Antimicrobial Chemotherapy	2015	32
CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients Kok‐Yong Seng, Kim‐Hor Hee, Gaik Hong Soon, The Journal of Clinical Pharmacology Hematological MalignancyOncologyCytochrome P450 3APhysiologically-based Pharmacokinetic ModelingMedicine	2013	21
Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial Meera Gurumurthy, Rupangi Verma, Claire M. Naftalin, Journal of Antimicrobial Chemotherapy	2017	20
Acceleration effects on neck muscle strength: pilots vs. non-pilots. Kok‐Yong Seng, Pin-Min Lam, Peter Vee Sin Lee PubMed	2003	18
Sensitivity analysis on a physiologically-based pharmacokinetic and pharmacodynamic model for diisopropylfluorophosphate-induced toxicity in mice and rats Kaizhen Chen, Shiyi Teo, Kok‐Yong Seng Toxicology Mechanisms and Methods	2009	15
Calibration and validation of a physiologically based model for soman intoxication in the rat, marmoset, guinea pig and pig Kaizhen Chen, Kok‐Yong Seng Journal of Applied Toxicology	2011	12

Page 1